Sudo T - Search Results

1

The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers.

Mimori K, Nagahara H, Sudo T, Ishii H, Yamashita K, Barnard GF, Mori M. Mimori K, et al. Among authors: sudo t. J Surg Oncol. 2006 Jan 1;93(1):44-6. doi: 10.1002/jso.20426. J Surg Oncol. 2006. PMID: 16353180

2

Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases.

Mimori K, Ogawa K, Okamoto M, Sudo T, Inoue H, Mori M. Mimori K, et al. Among authors: sudo t. Eur J Surg Oncol. 2005 May;31(4):376-80. doi: 10.1016/j.ejso.2004.11.001. Epub 2005 Jan 11. Eur J Surg Oncol. 2005. PMID: 15837043

3

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.

Sudo T, Utsunomiya T, Mimori K, Nagahara H, Ogawa K, Inoue H, Wakiyama S, Fujita H, Shirouzu K, Mori M. Sudo T, et al. Br J Cancer. 2005 May 9;92(9):1754-8. doi: 10.1038/sj.bjc.6602531. Br J Cancer. 2005. PMID: 15856046 Free PMC article.

4

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M. Mimori K, et al. Among authors: sudo t. Cancer Res. 2006 Mar 1;66(5):2683-90. doi: 10.1158/0008-5472.CAN-05-2509. Cancer Res. 2006. PMID: 16510588

5

Identification of EGFR mutations in esophageal cancer.

Sudo T, Mimori K, Nagahara H, Utsunomiya T, Fujita H, Tanaka Y, Shirouzu K, Inoue H, Mori M. Sudo T, et al. Eur J Surg Oncol. 2007 Feb;33(1):44-8. doi: 10.1016/j.ejso.2006.10.034. Epub 2006 Dec 4. Eur J Surg Oncol. 2007. PMID: 17142003

6

FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.

Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. Nishida N, et al. Among authors: sudo t. Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28. Ann Surg Oncol. 2011. PMID: 20803080

7

MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.

Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. Nishida N, et al. Among authors: sudo t. Clin Cancer Res. 2011 May 1;17(9):2725-33. doi: 10.1158/1078-0432.CCR-10-2132. Epub 2011 Jan 10. Clin Cancer Res. 2011. PMID: 21220473

8

MicroRNA miR-125b is a prognostic marker in human colorectal cancer.

Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H, Mori M. Nishida N, et al. Among authors: sudo t. Int J Oncol. 2011 May;38(5):1437-43. doi: 10.3892/ijo.2011.969. Epub 2011 Mar 10. Int J Oncol. 2011. PMID: 21399871

9

Histone deacetylase 1 expression in gastric cancer.

Sudo T, Mimori K, Nishida N, Kogo R, Iwaya T, Tanaka F, Shibata K, Fujita H, Shirouzu K, Mori M. Sudo T, et al. Oncol Rep. 2011 Oct;26(4):777-82. doi: 10.3892/or.2011.1361. Epub 2011 Jun 27. Oncol Rep. 2011. PMID: 21725604

10

Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.

Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M. Kogo R, et al. Among authors: sudo t. Cancer Res. 2011 Oct 15;71(20):6320-6. doi: 10.1158/0008-5472.CAN-11-1021. Epub 2011 Aug 23. Cancer Res. 2011. PMID: 21862635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

762 results

Search Page

Filters